NCT06075524 - Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

June 15, 2015

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Lung CarcinomaLocally Advanced Malignant Solid NeoplasmLocally Advanced MelanomaMetastatic Lung CarcinomaMetastatic Malignant Solid NeoplasmMetastatic MelanomaStage III Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood and optional stool/tissue sample collection

OTHER

Electronic Health Record Review

Medical records are reviewed

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester